Data released in recent weeks indicated that the immunizing agent is 95% effective against Covid-19
Initially, the vaccine will be approved by the European Medicines Agency until December 31, before the Brexit transitiona United kingdom It should be the first Western country to agree to immunization against COVID-19 And start vaccination in 2020, according to the British newspaper financial times. The information is that the independent regulator may grant approval within the next few days. According to British government officials, vaccine doses from Pfizerin partnership with BiotechnologyDelivery of doses will begin shortly after official permission is obtained. The UK has ordered 40 million doses, bearing in mind that each person should need two. Preliminary data, involving 43,000 volunteers and released in recent weeks, indicated that the immunizing agent is 95% effective in preventing coronavirus.
Initially, the vaccine will be licensed by European Medicines Agency Until December 31, before moving from Brixi. However, the UK Medicines and Healthcare products Regulatory Agency The application may authorize in case of urgent public need. The Serum Oxford, with AstraZeneca, could go through the same process – but on Friday, 27, the government asked the regulator to analyze the data again. Before the UK, only Russia He approved a Covid-19 immunizing agent, Sputnik V – but doubts remain about the transparency of the studies and their results. we United States of AmericaEmergency approval can be obtained between December 8 and 10. Pfizer/BioNTech and Oxford/AstraZeneca provided the data to the EMA at the same time as well as to authorities in the United Kingdom, Canada, Japan and Australia.
Amelia Kensington is a contributor to Mediarunsearch.co.uk, covering a wide range of topics including news, politics, business, technology, sport, entertainment, and lifestyle. She focuses on delivering clear, balanced reporting and useful information that helps readers stay informed about current events and emerging developments. Her work highlights stories that matter to everyday audiences, presenting complex topics in an accessible and engaging way while maintaining a strong commitment to accuracy and relevance.